Juan Sanchez | VP, Corporate Communications & IR |
Sharon Mates | Co-Founder, Chairman, CEO & President |
Mark Neumann | EVP & Chief Commercial Officer |
Andrew Satlin | EVP & Chief Medical Officer |
Lawrence Hineline | SVP, Finance, CFO, Treasurer and Assistant Secretary |
Charles Duncan | Cantor Fitzgerald |
Marc Goodman | SVB Leerink |
Umer Raffat | Evercore |
Jessica Fye | JPMorgan Chase & Co. |
Sumant Kulkarni | Canaccord Genuity |
Bert Hazlett | BTIG |
Jason Butler | JMP Securities |
Andrew Tsai | Jefferies |
Good morning, ladies and gentlemen, and welcome to the Intra-Cellular Therapies Fourth Quarter and Full Year Ended December 31, 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today's conference call is being recorded.
I would now like to turn the conference over to your host, Dr.